Correlation Between Karyopharm Therapeutics and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Hookipa Pharma, you can compare the effects of market volatilities on Karyopharm Therapeutics and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Hookipa Pharma.
Diversification Opportunities for Karyopharm Therapeutics and Hookipa Pharma
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Karyopharm and Hookipa is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Hookipa Pharma
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Hookipa Pharma. In addition to that, Karyopharm Therapeutics is 1.04 times more volatile than Hookipa Pharma. It trades about -0.03 of its total potential returns per unit of risk. Hookipa Pharma is currently generating about -0.03 per unit of volatility. If you would invest 950.00 in Hookipa Pharma on August 25, 2024 and sell it today you would lose (735.00) from holding Hookipa Pharma or give up 77.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. Hookipa Pharma
Performance |
| Timeline |
| Karyopharm Therapeutics |
| Hookipa Pharma |
Karyopharm Therapeutics and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and Hookipa Pharma
The main advantage of trading using opposite Karyopharm Therapeutics and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| Hookipa Pharma vs. Eliem Therapeutics | Hookipa Pharma vs. HCW Biologics | Hookipa Pharma vs. RenovoRx | Hookipa Pharma vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |